
Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced new real-world data demonstrating that its NeuroStar transcranial magnetic stimulation (TMS) therapy delivers meaningful improvement in depression symptoms among adolescents and young adults. …
Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS Read More